Skip to main content
. 2022 Jan 25;2022:9707206. doi: 10.1155/2022/9707206

Figure 1.

Figure 1

MAGI2-AS3 exhibits low expression in cervical cancer (a) MAGI2-AS3 has a lower expression in cervical cancer tissues than matched adjacent normal tissues. (b) MAGI2-AS3 was downregulated in cervical cancer patients at III-IV stage compared with the I-II stage. (c) MAGI2-AS3 expression was lower in cervical cancer cell lines than the normal cervix epithelial cells. (d) Kaplan–Meier curve indicated that downregulation of MAGI2-AS3 predicted a worse prognosis.